Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief

This article was originally published in The Tan Sheet

Executive Summary

McNeil manufacturing review spurs recalls

You may also be interested in...

Government Weighs In For Shareholders In Matrixx Supreme Court Case

The federal government says materiality should be the standard for deciding when firms must disclose information about problems to shareholders, arguing that Matrixx Initiatives presents a "false choice" between disclosing all information or only that considered statistically significant.

Trade Groups Back Matrixx On AER Disclosure In Supreme Court Case

Blanket disclosure of all adverse event reports would be "detrimental to investors and consumers," trade groups say in a brief supporting Matrixx Initiatives in its dispute with shareholders

Tylenol Yields Positive Results In Consumer Perception Study Despite Recall

A study of consumer brand perception finds "a great reservoir of goodwill" remains for Tylenol despite the manufacturing problems and recalls that have haunted the Johnson & Johnson brand in 2010

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts